Brokerages Set DENTSPLY SIRONA Inc. (XRAY) Target Price at $68.36

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) has received an average rating of “Buy” from the fifteen analysts that are currently covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell recommendation, three have given a hold recommendation and nine have given a buy recommendation to the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is $67.09.

A number of equities analysts have weighed in on XRAY shares. Zacks Investment Research upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $72.00 price target on the stock in a report on Thursday, July 13th. HC Wainwright assumed coverage on shares of DENTSPLY SIRONA in a report on Tuesday, July 11th. They set a “buy” rating and a $74.00 target price on the stock. BidaskClub upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a report on Friday, June 30th. Cleveland Research raised shares of DENTSPLY SIRONA from a “neutral” rating to a “buy” rating in a research note on Tuesday, May 23rd. Finally, Stifel Nicolaus reaffirmed a “buy” rating and set a $66.00 price target (down previously from $70.00) on shares of DENTSPLY SIRONA in a research note on Thursday.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in XRAY. Alps Advisors Inc. raised its position in DENTSPLY SIRONA by 0.3% in the second quarter. Alps Advisors Inc. now owns 7,523 shares of the medical instruments supplier’s stock valued at $488,000 after buying an additional 20 shares in the last quarter. Ropes Wealth Advisors LLC raised its position in DENTSPLY SIRONA by 0.3% in the first quarter. Ropes Wealth Advisors LLC now owns 9,003 shares of the medical instruments supplier’s stock valued at $562,000 after buying an additional 29 shares in the last quarter. Wetherby Asset Management Inc. raised its position in DENTSPLY SIRONA by 0.6% in the second quarter. Wetherby Asset Management Inc. now owns 5,004 shares of the medical instruments supplier’s stock valued at $324,000 after buying an additional 30 shares in the last quarter. HighTower Advisors LLC raised its position in DENTSPLY SIRONA by 0.6% in the first quarter. HighTower Advisors LLC now owns 6,823 shares of the medical instruments supplier’s stock valued at $424,000 after buying an additional 39 shares in the last quarter. Finally, BRYN MAWR TRUST Co raised its position in DENTSPLY SIRONA by 0.5% in the second quarter. BRYN MAWR TRUST Co now owns 12,064 shares of the medical instruments supplier’s stock valued at $782,000 after buying an additional 65 shares in the last quarter. Hedge funds and other institutional investors own 95.17% of the company’s stock.

WARNING: “Brokerages Set DENTSPLY SIRONA Inc. (XRAY) Target Price at $68.36” was reported by Transcript Daily and is the sole property of of Transcript Daily. If you are reading this article on another publication, it was illegally stolen and republished in violation of US & international trademark and copyright law. The correct version of this article can be viewed at https://transcriptdaily.com/2017/08/13/dentsply-sirona-inc-xray-given-consensus-recommendation-of-buy-by-analysts-updated-updated-updated.html.

Shares of DENTSPLY SIRONA (NASDAQ XRAY) opened at 55.33 on Tuesday. DENTSPLY SIRONA has a 52-week low of $54.49 and a 52-week high of $65.68. The company’s market capitalization is $12.70 billion. The company’s 50 day moving average price is $62.91 and its 200 day moving average price is $62.30.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $0.65. DENTSPLY SIRONA had a negative net margin of 20.57% and a positive return on equity of 7.24%. The firm had revenue of $992.70 million for the quarter, compared to analyst estimates of $1 billion. During the same quarter last year, the business earned $0.76 earnings per share. DENTSPLY SIRONA’s revenue was down 2.9% compared to the same quarter last year. On average, analysts predict that DENTSPLY SIRONA will post $2.73 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 13th. Shareholders of record on Friday, September 29th will be paid a $0.0875 dividend. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $0.35 annualized dividend and a yield of 0.63%. DENTSPLY SIRONA’s dividend payout ratio is presently -10.09%.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Analyst Recommendations for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply